ARRIVENT ANNOUNCES INITIAL PHASE 1 DATA FOR CDH17-TARGETED ADC ARR-217 IN PATIENTS WITH GASTROINTESTINAL CANCERS AT ESMO CONGRESS 2026

Reuters · 1d ago

Please log in to view news